Akinobu Maeda Selected Research

Akinobu Maeda Research Topics

Disease

14	Hypertension (High Blood Pressure) 05/2015 - 11/2009
7	Chronic Renal Insufficiency 01/2014 - 01/2011
4	Hypertrophy 03/2017 - 05/2010
4	Abdominal Obesity 03/2017 - 01/2013
3	Obesity 03/2017 - 01/2013
3	Body Weight (Weight, Body) 01/2014 - 01/2013
2	Fibrosis (Cirrhosis) 07/2017 - 10/2011
2	Insulin Resistance 03/2017 - 01/2012
2	Inflammation (Inflammations) 03/2017 - 10/2011
2	Albuminuria 01/2014 - 07/2013
2	Cardiomegaly (Heart Hypertrophy) 08/2013 - 05/2010
2	Proteinuria 03/2013 - 11/2009
1	Ureteral Obstruction 06/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2013
1	Peripheral Arterial Disease 04/2013
1	Atherosclerosis 04/2013
1	Dyslipidemias (Dyslipidemia) 04/2013
1	Essential Hypertension 08/2012
1	Disease Progression 01/2012
1	Eosinophilia 01/2012
1	Hypertriglyceridemia 01/2012
1	Starvation 07/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2011
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2010
1	AIDS-Related Complex (ARC) 07/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2009
1	Prostatic Neoplasms (Prostate Cancer) 09/2006
1	Genomic Instability 09/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2017 - 05/2010
7	Angiotensin IIIBA 03/2017 - 05/2010
5	Type 1 Angiotensin ReceptorIBA 03/2017 - 05/2010
4	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2011
3	AlbuminsIBA 01/2014 - 01/2011
3	olmesartanIBA 01/2014 - 10/2011
3	Therapeutic UsesIBA 01/2014 - 10/2011
3	CreatinineIBA 01/2014 - 01/2011
3	aliskiren FDA Link 07/2013 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 01/2011
2	AldosteroneIBA 09/2014 - 07/2013
2	SodiumIBA 09/2014 - 06/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 01/2012
2	Angiotensin Receptor AntagonistsIBA 01/2014 - 07/2013
2	ReninIBA 08/2013 - 07/2010
2	AngiotensinsIBA 08/2013 - 06/2013
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 07/2013 - 06/2013
2	Messenger RNA (mRNA)IBA 06/2013 - 07/2011
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2013 - 11/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	AdipokinesIBA 03/2017
1	bofu-tsusho-sanIBA 05/2015
1	Sodium-Hydrogen ExchangersIBA 09/2014
1	AngiotensinogenIBA 09/2014
1	Irbesartan FDA LinkGeneric 01/2014
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2013
1	N-Type Calcium Channels (N-Type Calcium Channel)IBA 08/2013
1	cilnidipineIBA 08/2013
1	Carrier Proteins (Binding Protein)IBA 07/2013
1	benazepril (Briem)FDA LinkGeneric 07/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Epithelial Sodium ChannelsIBA 06/2013
1	oxidized low density lipoproteinIBA 04/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2013
1	calcium phosphateIBA 04/2013
1	azilsartanIBA 02/2013
1	LDL CholesterolIBA 01/2013
1	candesartanIBA 01/2012
1	SaltsIBA 10/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2011
1	Collagen Type I (Type I Collagen)IBA 10/2011
1	Fibronectins (Fibronectin)IBA 10/2011
1	Fluvastatin FDA Link 01/2011
1	Valsartan (Vals)FDA Link 01/2011
1	p38 Mitogen-Activated Protein KinasesIBA 05/2010
1	Losartan (Cozaar)FDA LinkGeneric 11/2009
1	Telmisartan (Micardis)FDA Link 11/2009
1	AndrogensIBA 09/2006
1	Androgen Receptors (Androgen Receptor)IBA 09/2006

Therapy/Procedure

6	Therapeutics 05/2015 - 01/2011
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2017
1	Blood Component Removal (Apheresis) 04/2013